Samuel Adams, the flagship brand of the Boston Beer Company, is releasing a limited edition alcoholic beverage. However, it may not reach some locations in the United States because it was banned in at least 15 states.
Samuel Adams is releasing a new version of its beer brand called Utopia, but it was said to have been declared illegal due to its alcohol content. What’s more, according to CNN Business, even in regions where the new beer is allowed to be sold, customers may still have a hard time obtaining them.
It was reported that the company only brews about 13,000 bottles of the said strong beer every two years. Plus, it is costly that a 25.4-ounce bottle has a tag price of $240.
This new batch of Utopia beer will be Samuel Adam’s 12th edition, and it is expected to arrive in stores starting Oct. 11. For residents of Alabama, Arkansas, Georgia, Idaho, Missouri, Mississippi, Montana, North Carolina, New Hampshire, Oklahoma, Oregon, South Carolina, Utah, Vermont, or West Virginia, they will not have a chance to taste this brew due to the ban.
The said states prohibited the sale of this beer as it contains 28% alcohol by volume, which is over five times the potency of common beers in the U.S. Yahoo Life noted that in comparison, a regular beer only has 5% ABV while hard drinks, including vodka, rum and tequila can have about 40% ABV.
"We pioneered the barrel-aging and blending process of Utopias almost thirty years ago and continue that time-honored tradition today," Samuel Adams founder and brewer, Jim Koch, said in a press release as he announced the release of the latest version of Utopia beer and the charity bidding for the Jim Koch's Signed Number One Bottle of 2021 Utopias. "Since the introduction of Utopias in 2002, brewers have explored uncharted territory with each brew, experimenting with different kinds of aging barrels, new flavors, and different blending techniques. The result is always special, spirited, and worth waiting for."
Meanwhile, the first batch of Utopia beer came out in 2002, and its prices have continued to rise over the years. In 2017, it only cost $199, and in 2019, it was $209 per bottle.


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran 



